News

ASH Publishes Clinical Practice Guidelines on Diagnosis of Light Chain Amyloidosis
Jan 28, 2026
ASH Publishes Clinical Practice Guidelines on Diagnosis of Light Chain Amyloidosis
Recommendations outline best practices for diagnosing rare, complex bone marrow disorder(WASHINGTON — Jan. 28, 2026) — The American Society of Hematology (ASH)…
Read more
Amyloidosis Market Size, Smart Automation, Tech Challenges
Jan 24, 2026
Amyloidosis Market Size, Smart Automation, Tech Challenges
Amyloidosis Market Global Outlook, Country Deep-Dives & Strategic Opportunities (2024-2033) Market size (2024): USD 1.2 billion · Forecast (2033): 1.20 Billion…
Read more
Amvuttra gets EU approval to treat adults with ATTR-CM
Jan 23, 2026
Amvuttra gets EU approval to treat adults with ATTR-CM
The European Commission has expanded the indication of Amvuttra (vutrisiran) to include adults with ATTR amyloidosis with cardiomyopathy, or heart damage (ATTR-CM…
Read more
Why Amyloid Gets It Wrong – and How CAP Plans to Set It Right
Jan 23, 2026
Why Amyloid Gets It Wrong – and How CAP Plans to Set It Right
In hopes of improving outcomes of amyloidosis, a rare but serious disease caused by the buildup of abnormal amyloid deposits, The College of American Pathologists (…
Read more
Subscribe to